Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Chiedzo, Mpofu"'
Autor:
Gaetano Finocchiaro, Rodica Anghel, Hans Joerg Urban, George Fountzilas, Warren Mason, Martina Makrutzki, O. L. Chinot, Dana Cernea, François Ghiringhelli, Alba A. Brandes, Miguel Gil-Gil, Enrico Franceschi, Giuseppe Lombardi, Patrick Beauchesne, Chiedzo Mpofu, Josef Pichler, Antoine F. Carpentier, François Dubois, Vittorina Zagonel, Frank Saran, Anna K. Nowak
Publikováno v:
Oncologist
Oncologist, AlphaMed Press, In press, pp.theoncologist.2018-0290. ⟨10.1634/theoncologist.2018-0290⟩
Oncologist, AlphaMed Press, In press, pp.theoncologist.2018-0290. ⟨10.1634/theoncologist.2018-0290⟩
Background We assessed the efficacy and safety of bevacizumab (BEV) through multiple lines in patients with recurrent glioblastoma who had progressed after first-line treatment with radiotherapy, temozolomide, and BEV. Patients and Methods TAMIGA (NC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03b56aafa79f1107e7d482b6ce675ea6
https://europepmc.org/articles/PMC6459244/
https://europepmc.org/articles/PMC6459244/
Autor:
Antoine F. Carpentier, Olivier Chinot, Josef Pichler, Chiedzo Mpofu, Alba A. Brandes, Dana Cernea, Gaetano Finocchiaro, Miquel Gil Gil, Martina Makrutzki, Warren P. Mason, George Fountzilas, Hans-Joerg Urban, François Dubois, Frank Saran, Anna K. Nowak, Vittorina Zagonel
Bevacizumab (anti-vascular endothelial growth factor) prolongs progression-free survival (PFS) in newly diagnosed and recurrent glioblastoma. We hypothesized overall-survival (OS) benefit from continuing bevacizumab (BEV) through multiple lines of tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::717cf3112a49a1c2bceffd4a4668c40c
https://europepmc.org/articles/PMC5693008/
https://europepmc.org/articles/PMC5693008/
Autor:
Axel, Finckh, Jacques Eric, Gottenberg, Chiedzo, Mpofu, William, G. Bensen, Andrea, Rubbert Roth, Fedra, Irazoque, Victor, Martı’nez Taboada, Carol, Chung, Lykke, Hinsch Gylvin, Ferri, Clodoveo, Paul, Emery
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3674::61bd573923b99936840e6f4561155167
https://hdl.handle.net/11380/1064150
https://hdl.handle.net/11380/1064150
Autor:
Stuart Marshall–Clarke, Jonathan M. Rhodes, A McGoldrick, Carol L. Roberts, Chiedzo Mpofu, Andrew Cross, Steven W. Edwards, C. Anthony Hart, Sreedhar Subramanian, Barry J. Campbell
Publikováno v:
Gastroenterology. 133(5)
Crohn's disease (CD) is mimicked by inherited phagocyte disorders and is associated with circulating antibodies against yeast mannan (anti-Saccharomyces cerevisiae antibody; ASCA). We speculated that mannans might impair phagocyte function.S cerevisi
Publikováno v:
The Cochrane Library
BACKGROUND: Patients with longstanding ulcerative colitis and colonic Crohn's disease have an increased risk of colorectal cancer (CRC) compared with the general population. This review assessed the evidence that endoscopic surveillance may prolong l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c064e90ec038e9f116e03d37ea56e419
https://doi.org/10.1002/14651858.cd000279.pub3
https://doi.org/10.1002/14651858.cd000279.pub3
Autor:
Helen M, Martin, Barry J, Campbell, C Anthony, Hart, Chiedzo, Mpofu, Manu, Nayar, Ravinder, Singh, Hans, Englyst, Helen F, Williams, Jonathan M, Rhodes
Publikováno v:
Gastroenterology. 127(1)
Altered mucosal glycosylation in inflammatory bowel disease and colon cancer could affect mucosal bacterial adherence. This study aimed to quantify and characterize mucosa-associated and intramucosal bacteria, particularly Escherichia coli, in these
Publikováno v:
Annals of the Rheumatic Diseases. 62:1133-1134
Scleroderma renal crisis is one of the most life threatening complications of scleroderma. Enteric hyperoxaluria complicates extensive disease or resection of the small intestine in the presence of an intact colon, and is associated with calcium oxal
Publikováno v:
Gastroenterology. 124:A322
Publikováno v:
Clinical Science. 102:9P-9P